Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells.
Sayedeh Azimeh HosseiniMahdi GhatrehsamaniHajar YaghoobiFatemeh ElahianSeyed Abbas MirzaeiPublished in: Epigenomics (2024)
Background: The objective of this research was to determine whether HDAC2 function is associated with gastric cancer progression. Methods: HDAC2 was knocked out in EPG85.257 cells using CRISPR/Cas9 and tumorigenesis pathways were evaluated. Results: Cell proliferation, colony formation, wound healing and transwell invasion were inhibited in ΔHDAC2:EPG85.257 cells. Quantitative analyses revealed a significant downregulation of MMP1, p53, Bax, MAPK1, MAPK3, pro-Caspase3, ERK1/2, p-ERK1/2, AKT1/2/3, p-AKT1/2/3, p-NF-κB (p65), Twist, Snail and p-FAK transcripts/proteins, while SIRT1, PTEN, p21 and Caspase3 were upregulated in ΔHDAC2:EPG85.257 cells. Conclusion: These results indicated that HDAC2 enhanced migration, colony formation and transmigration ability. HDAC2 inhibition may improve gastric cancer chemotherapy pathways.
Keyphrases
- induced apoptosis
- signaling pathway
- histone deacetylase
- cell proliferation
- pi k akt
- cell cycle arrest
- oxidative stress
- cell death
- endoplasmic reticulum stress
- epithelial mesenchymal transition
- crispr cas
- gene expression
- dna methylation
- cell cycle
- high resolution
- wound healing
- squamous cell carcinoma
- single cell
- radiation therapy
- mass spectrometry
- anti inflammatory
- lps induced
- nuclear factor